A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published in PLOS ONE. The study, led by researchers with the U.S...
Комментариев нет:
Отправить комментарий